NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 133 filers reported holding NOVAVAX INC in Q1 2017. The put-call ratio across all filers is 0.95 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $2,000 | -66.7% | 3,500 | 0.0% | 0.00% | – |
Q4 2018 | $6,000 | -40.0% | 3,500 | -36.4% | 0.00% | – |
Q3 2018 | $10,000 | +42.9% | 5,499 | 0.0% | 0.00% | – |
Q2 2018 | $7,000 | -36.4% | 5,499 | 0.0% | 0.00% | – |
Q1 2018 | $11,000 | +57.1% | 5,499 | -0.0% | 0.00% | – |
Q4 2017 | $7,000 | -30.0% | 5,500 | -35.3% | 0.00% | – |
Q3 2017 | $10,000 | 0.0% | 8,500 | 0.0% | 0.00% | – |
Q2 2017 | $10,000 | -9.1% | 8,500 | 0.0% | 0.00% | – |
Q1 2017 | $11,000 | 0.0% | 8,500 | 0.0% | 0.00% | – |
Q4 2016 | $11,000 | -38.9% | 8,500 | 0.0% | 0.00% | -100.0% |
Q3 2016 | $18,000 | -71.0% | 8,500 | 0.0% | 0.00% | -66.7% |
Q2 2016 | $62,000 | +40.9% | 8,500 | 0.0% | 0.00% | +50.0% |
Q1 2016 | $44,000 | -30.2% | 8,500 | +13.3% | 0.00% | -33.3% |
Q4 2015 | $63,000 | -1.6% | 7,500 | -16.7% | 0.00% | 0.0% |
Q3 2015 | $64,000 | -17.9% | 9,000 | +28.6% | 0.00% | 0.0% |
Q2 2015 | $78,000 | +200.0% | 7,000 | +125.8% | 0.00% | +200.0% |
Q1 2015 | $26,000 | +188.9% | 3,100 | +106.7% | 0.00% | – |
Q4 2014 | $9,000 | – | 1,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alden Global Capital LLC | 600,000 | $4,362,000 | 3.76% |
DAFNA Capital Management LLC | 550,000 | $3,999,000 | 3.17% |
BB BIOTECH AG | 8,330,000 | $60,559,000 | 2.39% |
HARVEY CAPITAL MANAGEMENT INC | 602,750 | $4,381,000 | 2.20% |
NORTHPOINTE CAPITAL LLC | 2,124,035 | $15,442,000 | 1.82% |
Cormorant Asset Management, LP | 1,619,608 | $11,775,000 | 1.67% |
WILLIAM HARRIS INVESTORS INC | 667,922 | $4,856,000 | 1.22% |
Eventide Asset Management | 2,179,700 | $15,846,000 | 0.97% |
SECTORAL ASSET MANAGEMENT INC | 912,305 | $6,632,000 | 0.68% |
Rock Springs Capital Management LP | 852,500 | $6,198,000 | 0.46% |